FDA inspection
Imprimis NJOF, LLC: FDA inspection ending Apr 3, 2024
FDA inspection 1231238 · Official Action Indicated (OAI) · Ledgewood, NJ
Key facts
| Inspection ID | 1231238 |
|---|---|
| Firm | Imprimis NJOF, LLC |
| FEI number | 3013024146 |
| Address | 1705 Route 46 Ste 6B |
| City | Ledgewood |
| State | NJ |
| ZIP | 07852 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Apr 3, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data